Mind a depresszió, mind a diabetes mellitus napjaink és várhatóan jövőnk népbetegségei. Mára kellő mennyiségű, nagy betegszámú vizsgálat bizonyította, hogy cukorbetegekben az átlagpopulációhoz képest gyakrabban jelentkezik depresszió. A két betegség együttes fennállása fokozott veszélyt jelent a betegek számára, hiszen a komorbiditás kedvezőtlenül befolyásolja a diabetes kezelhetőségét, és ezáltal felgyorsítja a diabeteses szövődmények kialakulását, amelyek megjelenése a depresszív tünetek súlyosbításával egy ördögi kört indíthatnak be. A szerzők részletesen foglalkoznak a diabetes és a depresszió komplex kétirányú kapcsolatának elméleti és gyakorlati hátterével. Céljuk az, hogy felhívják arra a figyelmet, hogy a szénhidrát-anyagcsere rendezésének gátja lehet a depresszió, amelyet fel kell ismerni és szükség szerint kezelni kell, hogy javuljon cukorbetegeink életminősége. Orv. Hetil., 2011, 152, 498–504.
Unwin, N., Gan, D., Whiting, D.: The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res. Clin. Pract., 2010, 87, 2–3.
Whiting D. , 'The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action ' (2010 ) 87 Diabetes Res. Clin. Pract. : 2 -3 .
Federation, I. D.: The human, social and economic impact of diabetes. 2008. http://www.idf.org/home/index.cfm?node=41
Michaud, C. M., Murray, C. J., Bloom, B. R.: Burden of disease – implications for future research. JAMA, 2001, 285, 535–539.
Bloom B. R. , 'Burden of disease – implications for future research ' (2001 ) 285 JAMA : 535 -539 .
Kopp, M. S., Skrabski, A., Szedmak, S.: Socioeconomic factors, severity of depressive symptomatology, and sickness absence rate in the Hungarian population. Journal of Psychosomatic Research, 1995, 39, 1019–1029.
Szedmak S. , 'Socioeconomic factors, severity of depressive symptomatology, and sickness absence rate in the Hungarian population ' (1995 ) 39 Journal of Psychosomatic Research : 1019 -1029 .
Willis, T.: Diabetes: A Medical Odyssey. Tuckahoe, New York, 1971.
Willis T. , '', in Diabetes: A Medical Odyssey , (1971 ) -.
Anderson, R. J., Freedland, K. E., Clouse, R. E. és mtsai: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 2001, 24, 1069–1078.
Clouse R. E. , 'The prevalence of comorbid depression in adults with diabetes: a meta-analysis ' (2001 ) 24 Diabetes Care : 1069 -1078 .
Mezuk, B., Eaton, W. W., Albrecht, S. és mtsai: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care, 2008, 31, 2383–2390.
Albrecht S. , 'Depression and type 2 diabetes over the lifespan: a meta-analysis ' (2008 ) 31 Diabetes Care : 2383 -2390 .
Saydah, S. H., Brancati, F. L., Golden, S. H. és mtsai: Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab. Res. Rev., 2003, 19, 202–208.
Golden S. H. , 'Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample ' (2003 ) 19 Diabetes Metab. Res. Rev. : 202 -208 .
Palinkas, L. A., Barrett-Connor, E., Wingard, D. L.: Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet. Med., 1991, 8, 532–539.
Wingard D. L. , 'Type 2 diabetes and depressive symptoms in older adults: a population-based study ' (1991 ) 8 Diabet. Med. : 532 -539 .
Plotsky, P. M., Owens, M. J., Nemeroff, C. B.: Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am., 1998, 21, 293–307.
Nemeroff C. B. , 'Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis ' (1998 ) 21 Psychiatr. Clin. North Am. : 293 -307 .
Arana, G. W., Baldessarini, R. J., Ornsteen, M.: The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch. Gen. Psychiatry, 1985, 42, 1193–1204.
Ornsteen M. , 'The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review ' (1985 ) 42 Arch. Gen. Psychiatry : 1193 -1204 .
Holsboer, F., Von Bardeleben, U., Wiedemann, K. és mtsai: Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol. Psychiatry, 1987, 22, 228–234.
Wiedemann K. , 'Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression ' (1987 ) 22 Biol. Psychiatry : 228 -234 .
Rasgon, N. L., Kenna, H. A.: Insulin resistance in depressive disorders and Alzheimer’s disease: revisiting the missing link hypothesis. Neurobiol. Aging, 2005, 26, 103–107.
Kenna H. A. , 'Insulin resistance in depressive disorders and Alzheimer’s disease: revisiting the missing link hypothesis ' (2005 ) 26 Neurobiol. Aging : 103 -107 .
Lustman, P. J, Clouse, R. E.: Treatment of depression in diabetes: impact on mood and medical outcome. Journal of Psychosomatic Research, 2002, 53, 917–924.
Clouse R. E. , 'Treatment of depression in diabetes: impact on mood and medical outcome ' (2002 ) 53 Journal of Psychosomatic Research : 917 -924 .
Hirschfeld, R. M.: History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry, 2000, 61, 4–6.
Hirschfeld R. M. , 'History and evolution of the monoamine hypothesis of depression ' (2000 ) 61 J. Clin. Psychiatry : 4 -6 .
Lustman, P. J., Clouse, R. E., Freedland, K. E.: Management of major depression in adults with diabetes: Implications of recent clinical trials. Semin. Clin. Neuropsychiatry, 1998, 3, 102–114.
Freedland K. E. , 'Management of major depression in adults with diabetes: Implications of recent clinical trials ' (1998 ) 3 Semin. Clin. Neuropsychiatry : 102 -114 .
Zigmond, A. S., Snaith, R. P.: The hospital anxiety and depression scale. Acta Psychiatr. Scand., 1983, 67, 361–370.
Snaith R. P. , 'The hospital anxiety and depression scale ' (1983 ) 67 Acta Psychiatr. Scand. : 361 -370 .
Lustman, P. J., Anderson, R. J., Freedland, K. E. és mtsai: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care, 2000, 23, 934–942.
Freedland K. E. , 'Depression and poor glycemic control: a meta-analytic review of the literature ' (2000 ) 23 Diabetes Care : 934 -942 .
Richardson, L. K., Egede, L. E., Mueller, M. és mtsai: Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen. Hosp. Psychiatry, 2008, 30, 509–514.
Mueller M. , 'Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes ' (2008 ) 30 Gen. Hosp. Psychiatry : 509 -514 .
Gonzalez, J. S., Safren, S. A., Cagliero, E. és mtsai: Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care, 2007, 30, 2222–2227.
Cagliero E. , 'Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity ' (2007 ) 30 Diabetes Care : 2222 -2227 .
Wagner, J. A., Abbott, G. L., Heapy, A. és mtsai: Depressive symptoms and diabetes control in African Americans. J. Immigr. Minor Health, 2009, 11, 66–70.
Heapy A. , 'Depressive symptoms and diabetes control in African Americans ' (2009 ) 11 J. Immigr. Minor Health : 66 -70 .
De Groot, M., Anderson, R., Freedland, K. E. és mtsai: Association of depression and diabetes complications: a meta-analysis. Psychosom. Med., 2001, 63, 619–630.
Freedland K. E. , 'Association of depression and diabetes complications: a meta-analysis ' (2001 ) 63 Psychosom. Med. : 619 -630 .
Clouse, R. E., Lustman, P. J., Freedland, K. E. és mtsai: Depression and coronary heart disease in women with diabetes. Psychosom. Med., 2003, 65, 376–383.
Freedland K. E. , 'Depression and coronary heart disease in women with diabetes ' (2003 ) 65 Psychosom. Med. : 376 -383 .
Roy, M. S., Roy, A., Affouf, M.: Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom. Med., 2007, 69, 537–542.
Affouf M. , 'Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes ' (2007 ) 69 Psychosom. Med. : 537 -542 .
Sahota, P. K., Knowler, W. C., Looker, H. C.: Depression, diabetes, and glycemic control in an American Indian Community. J. Clin. Psychiatry, 2008, 69, 800–809.
Looker H. C. , 'Depression, diabetes, and glycemic control in an American Indian Community ' (2008 ) 69 J. Clin. Psychiatry : 800 -809 .
Gross, R., Olfson, M., Gameroff, M. J. és mtsai: Depression and glycemic control in Hispanic primary care patients with diabetes. J. Gen. Intern. Med., 2005, 20, 460–466.
Gameroff M. J. , 'Depression and glycemic control in Hispanic primary care patients with diabetes ' (2005 ) 20 J. Gen. Intern. Med. : 460 -466 .
Katon, W., Fan, M. Y., Unutzer, J. és mtsai: Depression and diabetes: a potentially lethal combination. J. Gen. Intern. Med., 2008, 23, 1571–1575.
Unutzer J. , 'Depression and diabetes: a potentially lethal combination ' (2008 ) 23 J. Gen. Intern. Med. : 1571 -1575 .
Zhang, X., Norris, S. L., Gregg, E. W. és mtsai: Depressive symptoms and mortality among persons with and without diabetes. Am. J. Epidemiol., 2005, 161, 652–660.
Gregg E. W. , 'Depressive symptoms and mortality among persons with and without diabetes ' (2005 ) 161 Am. J. Epidemiol. : 652 -660 .
Egede, L. E., Nietert, P. J., Zheng, D.: Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care, 2005, 28, 1339–1345.
Zheng D. , 'Depression and all-cause and coronary heart disease mortality among adults with and without diabetes ' (2005 ) 28 Diabetes Care : 1339 -1345 .
Lustman, P. J., Griffith, L. S., Clouse, R. E. és mtsai: Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosomatic Medicine, 1997, 59, 241–250.
Clouse R. E. , 'Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial ' (1997 ) 59 Psychosomatic Medicine : 241 -250 .
Lustman, P. J., Griffith, L. S., Freedland, K. E. és mtsai: Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med., 1998, 129, 613–621.
Freedland K. E. , 'Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial ' (1998 ) 129 Ann. Intern. Med. : 613 -621 .
Lustman, P. J., Clouse, R. E., Nix, B. D. és mtsai: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch. Gen. Psychiatry, 2006, 63, 521–529.
Nix B. D. , 'Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial ' (2006 ) 63 Arch. Gen. Psychiatry : 521 -529 .
Van Praag, H. M. Leijnse, B.: Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type. Psychopharmacologia, 1965, 8, 67–78.
Leijnse B. , 'Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type ' (1965 ) 8 Psychopharmacologia : 67 -78 .
Rabkin, J., Quitkin, F., Harrison, W. és mtsai: Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. J. Clin. Psychopharmacol., 1984, 4, 270–278.
Harrison W. , 'Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study ' (1984 ) 4 J. Clin. Psychopharmacol. : 270 -278 .
Max, M. B., Lynch, S. A., Muir, J. és mtsai: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med., 1992, 326, 1250–1256.
Muir J. , 'Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy ' (1992 ) 326 N. Engl. J. Med. : 1250 -1256 .
Van Tilburg, M. A., McCaskill, C. C., Lane, J. D. és mtsai: Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom. Med., 2001, 63, 551–555.
Lane J. D. , 'Depressed mood is a factor in glycemic control in type 1 diabetes ' (2001 ) 63 Psychosom. Med. : 551 -555 .
Goodnick, P. J.: Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Clin. Psychiatry, 2001, 13, 31–41.
Goodnick P. J. , 'Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy ' (2001 ) 13 Ann. Clin. Psychiatry : 31 -41 .
Lustman, P. J., Freedland, K. E., Griffith, L. S. és mtsai: Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care, 2000, 23, 618–623.
Griffith L. S. , 'Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial ' (2000 ) 23 Diabetes Care : 618 -623 .
Devane, C. L., Markowitz, J. S.: Psychoactive drug interactions with pharmacotherapy for diabetes. Psychopharmacol. Bull., 2002, 36, 40–52.
Markowitz J. S. , 'Psychoactive drug interactions with pharmacotherapy for diabetes ' (2002 ) 36 Psychopharmacol. Bull. : 40 -52 .
Fava, M.: Weight gain and antidepressants. J. Clin. Psychiatry, 2000, 61, 37–41.
Fava M. , 'Weight gain and antidepressants ' (2000 ) 61 J. Clin. Psychiatry : 37 -41 .
Elkin, I., Shea, M. T., Watkins, J. T. és mtsai: National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch. Gen. Psychiatry, 1989, 46, 971–982.; discussion 983.
Watkins J. T. , 'National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments ' (1989 ) 46 Arch. Gen. Psychiatry : 971 -982.; discussion 983 .
Lustman, P. J., Clouse, R. E.: Depression in diabetic patients: the relationship between mood and glycemic control. J. Diabetes Complications, 2005, 19, 113–122.
Clouse R. E. , 'Depression in diabetic patients: the relationship between mood and glycemic control ' (2005 ) 19 J. Diabetes Complications : 113 -122 .
Reza, M., Taylor, C. D., Towse, K. és mtsai: Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res. Clin. Pract., 2002, 55, 201–207.
Towse K. , 'Insulin improves well-being for selected elderly type 2 diabetic subjects ' (2002 ) 55 Diabetes Res. Clin. Pract. : 201 -207 .
Bradley, C., Witthaus, E., Stewart, J.: Treatment satisfaction and psychological well-being in patients with type 1 diabetes, treated with a new long-acting insulin, insulin glargine. Diabetes, 1999, 48, A353.
Stewart J. , 'Treatment satisfaction and psychological well-being in patients with type 1 diabetes, treated with a new long-acting insulin, insulin glargine ' (1999 ) 48 Diabetes : A353 -.